Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1955 Aug;18(3):225–227. doi: 10.1136/jnnp.18.3.225

RAUWOLFIA SERPENTINA (SERPASIL) IN PSYCHIATRY

J D Glynn 1
PMCID: PMC503243  PMID: 13252432

Full text

PDF
225

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. MULLER J. M., SCHLITTLER E., BEIN H. J. Reserpin, der sedative Wirkstoff aus Rauwolfia serpentina Benth. Experientia. 1952 Sep 15;8(9):338–338. doi: 10.1007/BF02174406. [DOI] [PubMed] [Google Scholar]
  2. TRAPOLD J. H., PLUMMER A. J., YONKMAN F. F. Cardiovascular and respiratory effects of serpasil, a new crystalline alkaloid from Rauwolfia serpentina Benth, in the dog. J Pharmacol Exp Ther. 1954 Feb;110(2):205–214. [PubMed] [Google Scholar]
  3. TRIPOD J., BEIN H. J., MEIER R. Characterization of central effects of serpasil (reserpin, a new alkaloid of Rauwolfia serpentina B.) and of their antagonistic reactions. Arch Int Pharmacodyn Ther. 1954 Jan;96(3-4):406–425. [PubMed] [Google Scholar]
  4. WILKINS R. W., JUDSON W. E., STONE R. W., HOLLANDER W., HUCKABEE W. E., FRIEDMAN I. H. Reserpine in the treatment of hypertension; a note on the relative dosage and effects. N Engl J Med. 1954 Mar 18;250(11):477–478. doi: 10.1056/NEJM195403182501107. [DOI] [PubMed] [Google Scholar]
  5. WILKINS R. W. New drug therapies in arterial hypertension. Ann Intern Med. 1952 Dec;37(6):1144–1155. doi: 10.7326/0003-4819-37-6-1144. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES